Relationship between renal tissues phospholipase A2 receptor and its serum antibody and clinical condition and prognosis of idiopathic membranous nephropathy: a meta-analysis

[1]  Chong Zhang,et al.  Clinical and Histological Features of Phospholipase A2 Receptor-Associated and Thrombospondin Type-I Domain-containing 7A-Associated Idiopathic Membranous Nephropathy: A Single Center Retrospective Study from China , 2018, Medical science monitor : international medical journal of experimental and clinical research.

[2]  K. Wissing,et al.  Membranous Nephropathy and Anti-Podocytes Antibodies: Implications for the Diagnostic Workup and Disease Management , 2018, BioMed research international.

[3]  C. Hao,et al.  Response to immunosuppressive therapy in PLA2R- associated and non-PLA2R- associated idiopathic membranous nephropathy: a retrospective, multicenter cohort study , 2017, BMC Nephrology.

[4]  Hai-Xia Li,et al.  Serum anti-PLA2R antibody and glomerular PLA2R deposition in Chinese patients with membranous nephropathy , 2017, Medicine.

[5]  K. Dahan,et al.  Prognostic value of PLA2R autoimmunity detected by measurement of anti-PLA2R antibodies combined with detection of PLA2R antigen in membranous nephropathy: A single-centre study over 14 years , 2017, PloS one.

[6]  J. Damoiseaux,et al.  Supplementary Material for: Anti-PLA2R Antibodies as a Prognostic Factor in PLA2R-Related Membranous Nephropathy , 2017 .

[7]  V. Jha,et al.  PLA2R antibodies, glomerular PLA2R deposits and variations in PLA2R1 and HLA-DQA1 genes in primary membranous nephropathy in South Asians. , 2016, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[8]  W. Luo,et al.  Detection and clinical significance of glomerular M‐type phospholipase A2 receptor in patients with idiopathic membranous nephropathy , 2016, Internal medicine journal.

[9]  Jian-Si Li,et al.  Serum Anti-PLA2R Antibody Predicts Treatment Outcome in Idiopathic Membranous Nephropathy , 2016, American Journal of Nephrology.

[10]  Xinling Liang,et al.  A follow-up analysis of positron emission tomography/computed tomography in detecting hidden malignancies at the time of diagnosis of membranous nephropathy , 2016, Oncotarget.

[11]  W. Yuan,et al.  [Expression of renal PLA2R in patients with idiopathic membranous nephropathy and its relationship with the curative effect of immunotherapy]. , 2016, Zhonghua yi xue za zhi.

[12]  Y. Kim,et al.  Anti-Phospholipase A2 Receptor Antibody as Prognostic Indicator in Idiopathic Membranous Nephropathy , 2015, American Journal of Nephrology.

[13]  P. van Paassen,et al.  Anti-PLA2R Antibodies as a Prognostic Factor in PLA2R-Related Membranous Nephropathy , 2015, American Journal of Nephrology.

[14]  G. Remuzzi,et al.  Anti-Phospholipase A2 Receptor Antibody Titer Predicts Post-Rituximab Outcome of Membranous Nephropathy. , 2015, Journal of the American Society of Nephrology : JASN.

[15]  Huhai Zhang,et al.  Diagnostic accuracy of PLA2R autoantibodies and glomerular staining for the differentiation of idiopathic and secondary membranous nephropathy: an updated meta-analysis , 2015, Scientific Reports.

[16]  J. Wetzels,et al.  Association of anti-PLA₂R antibodies with outcomes after immunosuppressive therapy in idiopathic membranous nephropathy. , 2014, Clinical journal of the American Society of Nephrology : CJASN.

[17]  D. Salant,et al.  Membranous nephropathy: from models to man. , 2014, The Journal of clinical investigation.

[18]  U. Panzer,et al.  Phospholipase A2 receptor autoantibodies and clinical outcome in patients with primary membranous nephropathy. , 2014, Journal of the American Society of Nephrology : JASN.

[19]  A. Segarra-Medrano,et al.  Evolución del título de anticuerpos contra el receptor tipo M de la fosfolipasa A2 y respuesta clínica en pacientes con nefropatía membranosa idiopática tratados con tacrolimus , 2014 .

[20]  N. Valtierra,et al.  Evolution of antibody titre against the M-type phospholipase A2 receptor and clinical response in idiopathic membranous nephropathy patients treated with tacrolimus. , 2014, Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia.

[21]  V. Jha,et al.  Infusion of autologous bone marrow mononuclear cells leads to transient reduction in proteinuria in treatment refractory patients with Idiopathic membranous nephropathy , 2013, BMC Nephrology.

[22]  Y. Kim,et al.  Autoantibodies against Phospholipase A2 Receptor in Korean Patients with Membranous Nephropathy , 2013, PloS one.

[23]  J. Wetzels,et al.  Antiphospholipase A2 receptor antibody titer and subclass in idiopathic membranous nephropathy. , 2012, Journal of the American Society of Nephrology : JASN.

[24]  David M. Beck,et al.  Rituximab-induced depletion of anti-PLA2R autoantibodies predicts response in membranous nephropathy. , 2011, Journal of the American Society of Nephrology : JASN.

[25]  U. Panzer,et al.  An immunofluorescence test for phospholipase-A₂-receptor antibodies and its clinical usefulness in patients with membranous glomerulonephritis. , 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[26]  D. Salant,et al.  Anti-phospholipase A2 receptor antibody in membranous nephropathy. , 2011, Journal of the American Society of Nephrology : JASN.

[27]  克治 桑門.  海外論文紹介 : M-Type Phospholipase A2 Receptor as Target Antigen in Idiopathic Membranous Nephropathy , 2010 .

[28]  H. Debiec,et al.  Antigen identification in membranous nephropathy moves toward targeted monitoring and new therapy. , 2010, Journal of the American Society of Nephrology : JASN.

[29]  David M. Beck,et al.  M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. , 2009, The New England journal of medicine.

[30]  H. Trachtman,et al.  Idiopathic membranous nephropathy in pediatric patients: presentation, response to therapy, and long-term outcome , 2007, BMC nephrology.

[31]  C. Isacke,et al.  Structural Model for the Mannose Receptor Family Uncovered by Electron Microscopy of Endo180 and the Mannose Receptor* , 2006, Journal of Biological Chemistry.

[32]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[33]  J. Haymann,et al.  Antenatal membranous glomerulonephritis due to anti-neutral endopeptidase antibodies. , 2002, The New England journal of medicine.

[34]  M. Lazdunski,et al.  The Human 180-kDa Receptor for Secretory Phospholipases A2 , 1995, The Journal of Biological Chemistry.